291 related articles for article (PubMed ID: 22782891)
1. Targeting serous epithelial ovarian cancer with designer zinc finger transcription factors.
Lara H; Wang Y; Beltran AS; Juárez-Moreno K; Yuan X; Kato S; Leisewitz AV; Cuello Fredes M; Licea AF; Connolly DC; Huang L; Blancafort P
J Biol Chem; 2012 Aug; 287(35):29873-86. PubMed ID: 22782891
[TBL] [Abstract][Full Text] [Related]
2. Re-activation of a dormant tumor suppressor gene maspin by designed transcription factors.
Beltran A; Parikh S; Liu Y; Cuevas BD; Johnson GL; Futscher BW; Blancafort P
Oncogene; 2007 Apr; 26(19):2791-8. PubMed ID: 17057734
[TBL] [Abstract][Full Text] [Related]
3. Suppression of breast tumor growth and metastasis by an engineered transcription factor.
Beltran AS; Russo A; Lara H; Fan C; Lizardi PM; Blancafort P
PLoS One; 2011; 6(9):e24595. PubMed ID: 21931769
[TBL] [Abstract][Full Text] [Related]
4. Reactivation of MASPIN in non-small cell lung carcinoma (NSCLC) cells by artificial transcription factors (ATFs).
Beltran AS; Blancafort P
Epigenetics; 2011 Feb; 6(2):224-35. PubMed ID: 20948306
[TBL] [Abstract][Full Text] [Related]
5. Reprogramming epigenetic silencing: artificial transcription factors synergize with chromatin remodeling drugs to reactivate the tumor suppressor mammary serine protease inhibitor.
Beltran AS; Sun X; Lizardi PM; Blancafort P
Mol Cancer Ther; 2008 May; 7(5):1080-90. PubMed ID: 18483297
[TBL] [Abstract][Full Text] [Related]
6. The paradoxical expression of maspin in ovarian carcinoma.
Sood AK; Fletcher MS; Gruman LM; Coffin JE; Jabbari S; Khalkhali-Ellis Z; Arbour N; Seftor EA; Hendrix MJ
Clin Cancer Res; 2002 Sep; 8(9):2924-32. PubMed ID: 12231537
[TBL] [Abstract][Full Text] [Related]
7. Maspin overexpression correlates with positive response to primary chemotherapy in ovarian cancer patients.
Klasa-Mazurkiewicz D; Narkiewicz J; Milczek T; Lipińska B; Emerich J
Gynecol Oncol; 2009 Apr; 113(1):91-8. PubMed ID: 19193429
[TBL] [Abstract][Full Text] [Related]
8. ATF-2 controls transcription of Maspin and GADD45 alpha genes independently from p53 to suppress mammary tumors.
Maekawa T; Sano Y; Shinagawa T; Rahman Z; Sakuma T; Nomura S; Licht JD; Ishii S
Oncogene; 2008 Feb; 27(8):1045-54. PubMed ID: 17700520
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation of maspin expression in human ovarian carcinoma cells.
Rose SL; Fitzgerald MP; White NO; Hitchler MJ; Futscher BW; De Geest K; Domann FE
Gynecol Oncol; 2006 Aug; 102(2):319-24. PubMed ID: 16457875
[TBL] [Abstract][Full Text] [Related]
10. Development of a syngeneic mouse model of epithelial ovarian cancer.
Quinn BA; Xiao F; Bickel L; Martin L; Hua X; Klein-Szanto A; Connolly DC
J Ovarian Res; 2010 Oct; 3():24. PubMed ID: 20958993
[TBL] [Abstract][Full Text] [Related]
11. Snail transcription factor negatively regulates maspin tumor suppressor in human prostate cancer cells.
Neal CL; Henderson V; Smith BN; McKeithen D; Graham T; Vo BT; Odero-Marah VA
BMC Cancer; 2012 Aug; 12():336. PubMed ID: 22857708
[TBL] [Abstract][Full Text] [Related]
12. Mammary serine protease inhibitor and CD138 immunohistochemical expression in ovarian serous and clear cell carcinomas.
Hasby EA
Tumour Biol; 2016 Apr; 37(4):4889-900. PubMed ID: 26526579
[TBL] [Abstract][Full Text] [Related]
13. Maspin expression in epithelial ovarian cancer and associations with poor prognosis: a Gynecologic Oncology Group study.
; Secord AA; Lee PS; Darcy KM; Havrilesky LJ; Grace LA; Marks JR; Berchuck A
Gynecol Oncol; 2006 Jun; 101(3):390-7. PubMed ID: 16551475
[TBL] [Abstract][Full Text] [Related]
14. Expression and subcellular localization of maspin in human ovarian epithelial neoplasms: correlation with clinicopathologic features.
Abd El-Wahed MM
J Egypt Natl Canc Inst; 2005 Sep; 17(3):173-83. PubMed ID: 16799655
[TBL] [Abstract][Full Text] [Related]
15. Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype.
Villares GJ; Zigler M; Dobroff AS; Wang H; Song R; Melnikova VO; Huang L; Braeuer RR; Bar-Eli M
Proc Natl Acad Sci U S A; 2011 Jan; 108(2):626-31. PubMed ID: 21187389
[TBL] [Abstract][Full Text] [Related]
16. TAp63gamma can substitute for p53 in inducing expression of the maspin tumor suppressor.
Spiesbach K; Tannapfel A; Mössner J; Engeland K
Int J Cancer; 2005 Apr; 114(4):555-62. PubMed ID: 15578720
[TBL] [Abstract][Full Text] [Related]
17. The regulation of MASPIN expression in epithelial ovarian cancer: association with p53 status, and MASPIN promoter methylation: a gynecologic oncology group study.
Alvarez Secord A; Darcy KM; Hutson A; Huang Z; Lee PS; Jewell EL; Havrilesky LJ; Markman M; Muggia F; Murphy SK
Gynecol Oncol; 2011 Nov; 123(2):314-9. PubMed ID: 21903246
[TBL] [Abstract][Full Text] [Related]
18. BRCA1 185delAG mutant protein, BRAt, up-regulates maspin in ovarian epithelial cells.
O'Donnell JD; Linger RJ; Kruk PA
Gynecol Oncol; 2010 Feb; 116(2):262-8. PubMed ID: 19906413
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen induces the expression of maspin through estrogen receptor-alpha.
Liu Z; Shi HY; Nawaz Z; Zhang M
Cancer Lett; 2004 Jun; 209(1):55-65. PubMed ID: 15145521
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneous expression of serine protease inhibitor maspin in ovarian cancer.
Bauerschlag DO; Habermann M; Weimer J; Meinhold-Heerlein I; Hilpert F; Weigel M; Bauer M; Mundhenke C; Jonat W; Maass N; Schem C
Anticancer Res; 2010 Jul; 30(7):2739-44. PubMed ID: 20683007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
